Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127737071 | 12773707 | 1 | I | 201309 | 20160920 | 20160923 | 20160923 | EXP | AT-AMGEN-AUTSP2016128903 | AMGEN | 42.00 | YR | A | F | Y | 0.00000 | 20160922 | MD | AT | AT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127737071 | 12773707 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | U | 125031 | UNKNOWN FORMULATION | ||||||||
| 127737071 | 12773707 | 2 | SS | PERJETA | PERTUZUMAB | 1 | Unknown | 6 CYCLES | 0 | ||||||||||
| 127737071 | 12773707 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | 6 CYCLES | 0 | ||||||||||
| 127737071 | 12773707 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 127737071 | 12773707 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | 6 CYCLES | 0 | ||||||||||
| 127737071 | 12773707 | 6 | C | LETROZOL | LETROZOLE | 1 | UNK | 0 | |||||||||||
| 127737071 | 12773707 | 7 | C | DENOSUMAB | DENOSUMAB | 1 | UNK | 0 | |||||||||||
| 127737071 | 12773707 | 8 | C | EXEMESTAN | EXEMESTANE | 1 | UNK | 0 | |||||||||||
| 127737071 | 12773707 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 127737071 | 12773707 | 10 | C | PREGABALIN. | PREGABALIN | 1 | 300 MG, QD (DAILY) | 0 | 300 | MG | QD | ||||||||
| 127737071 | 12773707 | 11 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 127737071 | 12773707 | 12 | C | TRAMADOL. | TRAMADOL | 1 | 300 MG, UNK | 0 | 300 | MG | |||||||||
| 127737071 | 12773707 | 13 | C | DULOXETINA | DULOXETINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127737071 | 12773707 | 1 | Product used for unknown indication |
| 127737071 | 12773707 | 2 | Breast cancer metastatic |
| 127737071 | 12773707 | 3 | Breast cancer metastatic |
| 127737071 | 12773707 | 5 | Breast cancer metastatic |
| 127737071 | 12773707 | 6 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127737071 | 12773707 | OT |
| 127737071 | 12773707 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127737071 | 12773707 | Anaphylactic reaction | |
| 127737071 | 12773707 | Arthralgia | |
| 127737071 | 12773707 | Bone pain | |
| 127737071 | 12773707 | Cardiomyopathy | |
| 127737071 | 12773707 | Hypocalcaemia | |
| 127737071 | 12773707 | Hypokalaemia | |
| 127737071 | 12773707 | Hyponatraemia | |
| 127737071 | 12773707 | Jugular vein thrombosis | |
| 127737071 | 12773707 | Myalgia | |
| 127737071 | 12773707 | Nausea | |
| 127737071 | 12773707 | Pleural effusion | |
| 127737071 | 12773707 | Polyneuropathy | |
| 127737071 | 12773707 | Pulmonary congestion | |
| 127737071 | 12773707 | Subclavian vein thrombosis | |
| 127737071 | 12773707 | Vomiting | |
| 127737071 | 12773707 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127737071 | 12773707 | 2 | 20130819 | 201402 | 0 | |
| 127737071 | 12773707 | 3 | 20130819 | 201402 | 0 | |
| 127737071 | 12773707 | 4 | 201402 | 201406 | 0 | |
| 127737071 | 12773707 | 5 | 20130819 | 201402 | 0 | |
| 127737071 | 12773707 | 6 | 201402 | 0 |